中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 3
Mar.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(3): 497-500

Management of ablation techniques for liver cancer and establishment of a diverse team for liver cancer ablation

DOI: 10.3969/j.issn.1001-5256.2021.03.001

  • National Cancer Center; National Clinical Research Center for Cancer; Department of Interventional Therapy, Cancer Hospital of Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

  • Received Date: 2020-12-11
  • Accepted Date: 2020-12-14
  • Published Date: 2021-03-20
    Abstract
  • Ablation is one of the important treatment methods for liver cancer, and standard ablation techniques, scientific and rational therapeutic strategy, and close teamwork are important premises for a good clinical effect. Although the efficacy of ablation therapy for liver cancer has gradually increased with the continuous improvement of ablation techniques, there remains a high tumor recurrence rate, and therefore, there is an urgent need for the therapeutic strategies that can improve the efficacy of ablation therapy for liver cancer and the prognosis of patients. Establishment of a diverse team for liver cancer ablation is a new concept put forward on the basis of a conventional team for liver cancer ablation to meet the requirements of ablation therapy for liver cancer. Since a diverse team for liver cancer ablation has potential advantages over a conventional team, it may be a promising mode for establishing a team for liver cancer ablation.

     

    • FullText(HTML)
  • loading
    • References(24)
  • [1]
    European Association for the Study of the Liver, European Association for the Study of the Liver. EASL clinical practice guidelines: Management of hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1): 182-236. DOI: 10.1016/j.jhep.2018.03.019
    [2]
    VILLANUEVA A. Hepatocellular carcinoma[J]. N Engl J Med, 2019, 380(15): 1450-1462. DOI: 10.1056/NEJMra1713263
    [3]
    MARRERO JA, KULIK LM, SIRLIN CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 68(2): 723-750. DOI: 10.1002/hep.29913
    [4]
    NAULT JC, SUTTER O, NAHON P, et al. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations[J]. J Hepatol, 2018, 68(4): 783-797. DOI: 10.1016/j.jhep.2017.10.004
    [5]
    AHMED M, BRACE CL, LEE FT Jr, et al. Principles of and advances in percutaneous ablation[J]. Radiology, 2011, 258(2): 351-369. DOI: 10.1148/radiol.10081634
    [6]
    FINN RS, ZHU AX, FARAH W, et al. Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis[J]. Hepatology, 2018, 67(1): 422-435. DOI: 10.1002/hep.29486
    [7]
    GESCHWIND JFH, SOULEN MC. Interventional oncology: Principles and practice of image-guided cancer therapy (Second Edition)[M]. United Kingdom: Cambridge University Press, 2016: 3-43.
    [8]
    KNAVEL EM, BRACE CL. Tumor ablation: Common modalities and general practices[J]. Tech Vasc Interv Radiol, 2013, 16(4): 192-200. DOI: 10.1053/j.tvir.2013.08.002
    [9]
    CUCCHETTI A, PISCAGLIA F, CESCON M, et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma[J]. J Hepatol, 2013, 59(2): 300-307. DOI: 10.1016/j.jhep.2013.04.009
    [10]
    OKUWAKI Y, NAKAZAWA T, KOKUBU S, et al. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma[J]. Am J Gastroenterol, 2009, 104(11): 2747-2753. DOI: 10.1038/ajg.2009.414
    [11]
    KIM YS, LIM HK, RHIM H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors[J]. J Hepatol, 2013, 58(1): 89-97. DOI: 10.1016/j.jhep.2012.09.020
    [12]
    VELEZ E, GOLDBERG SN, KUMAR G, et al. Hepatic thermal ablation: Effect of device and heating parameters on local tissue reactions and distant tumor growth[J]. Radiology, 2016, 281(3): 782-792. DOI: 10.1148/radiol.2016152241
    [13]
    CHU KF, DUPUY DE. Thermal ablation of tumours: Biological mechanisms and advances in therapy[J]. Nat Rev Cancer, 2014, 14(3): 199-208. DOI: 10.1038/nrc3672
    [14]
    RAMASWAMY RS, TIWARI T, RAMASWAMY HF, et al. Teamwork and communication in interventional radiology[J]. J Radiol Nurs, 2017, 36(4): 261-264. DOI: 10.1016/j.jradnu.2017.10.003
    [15]
    STEER CJ, JACKSON PR, HORNBEAK H, et al. Team science and the physician-scientist in the age of grand health challenges[J]. Ann N Y Acad Sci, 2017, 1404(1): 3-16. DOI: 10.1111/nyas.13498
    [16]
    BALLANGRUD R, HUSEBØ SE, AASE K, et al. "Teamwork in hospitals": A quasi-experimental study protocol applying a human factors approach[J]. BMC Nurs, 2017, 16: 34. DOI: 10.1186/s12912-017-0229-z
    [17]
    ZHAO H, TSAUO JW, ZHANG XW, et al. Interventional radiology in China: Current status and future prospects[J]. Chin Med J (Engl), 2017, 130(11): 1371-1375. DOI: 10.4103/0366-6999.206355
    [18]
    GEOFFREY M, BELLMAN, KATHLEEN D. Extraordinary Groups: How ordinary teams achieve amazing results[M]. San Francisco, CA, the U. S: Jossey-Bass, 2009: 137-194.
    [19]
    ROSEN MA, DIAZGRANADOS D, DIETZ AS, et al. Teamwork in healthcare: Key discoveries enabling safer, high-quality care[J]. Am Psychol, 2018, 73(4): 433-450. DOI: 10.1037/amp0000298
    [20]
    American College of Radiology, Society of Interventional Radiology, Society of Neurointerventional Surgery, et al. Practice parameter for interventional clinical practice and management[J]. J Vasc Interv Radiol, 2015, 26(8): 1197-1204. DOI: 10.1016/j.jvir.2015.05.017
    [21]
    GERAGHTY A, PATERSON-BROWN S. Leadership and working in teams[J]. Surgery (Oxford), 2018, 36(9): 503-508. DOI: 10.1016/j.mpsur.2018.07.013
    [22]
    YANG CY, YANG HJ, WANG QL. The application and evaluation of "select-cultivate-appoint" flat management model for the management of talented researchers in the hospital[J]. Chin J Med Sci Res Manage, 2015, 28(2): 180-182, 196. (in Chinese) http://qikan.cqvip.com/Qikan/Article/Detail?id=664844981

    杨成良, 杨怀洁, 王青丽. 医院"选-培-用"扁平化人才管理模式的应用与效果评价[J]. 中华医学科研管理杂志, 2015, 28(2): 180-182, 196. http://qikan.cqvip.com/Qikan/Article/Detail?id=664844981
    [23]
    RONALD CG. Management by objectives: As developed by Peter Drucker, assisted by Harold Smiddy[J]. Acad Manage Rev, 1981, 6(2): 225-230. DOI: 10.5465/amr.1981.4287793
    [24]
    PORTER TH, STOLLER JK, ALLEN SJ. Team development among physician-leaders at the Cleveland Clinic[J]. Leadersh Health Serv (Bradf Engl), 2018, 31(2): 210-225. DOI: 10.1108/LHS-10-2017-0060
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (637) PDF downloads(89) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return